## L: Loews Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -2.1% below STRENGTH zone (3.0-6.0%); PEG 2.69 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($103.36)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Loews Corporation (L) Stock Price | Live Quotes & Charts | NYSE**
- Source: StocksToTrade | 20251201T090613 | Neutral | Relevance: 98%
- This document provides live stock quotes and charts for Loews Corporation (L), displaying its current stock price and daily change. It also includes sections for analyst ratings, noting that there are no ratings in the last three months, and indicates that earnings information is not currently available.

**2. Dir Berman Files To Sell 1,444 Of Loews Corp [L]**
- Source: TradingView | 20251201T225113 | Neutral | Relevance: 98%
- Ann E. Berman, a Director of Loews Corp (L), filed a Form 144 with the SEC on December 1, 2025, proposing to sell 1,444 shares of restricted securities. The sale is planned for December 1, 2025, through Fidelity Brokerage Services and is pursuant to a prearranged trading plan (10b5-1). This filing allows the sale to occur within 90 days of submission.

**3. Shareholder Tisch Files To Sell 200,000 Of Loews Corp [L]**
- Source: TradingView | 20251201T225113 | Neutral | Relevance: 98%
- Andrew H. Tisch, a shareholder of Loews Corp (L), filed a Form 144 with the SEC on December 1, 2025, indicating his intention to sell 200,000 restricted shares. The sale is planned for approximately December 1, 2025, through Watermill Institutional Trading LLC, and must occur within 90 days of the filing. This filing allows transparency regarding insider transactions of restricted securities.

**4. NYSE company (L) files Form 144 for 200,000-share planned sale**
- Source: Stock Titan | 20251201T222800 | Neutral | Relevance: 97%
- A shareholder of Loews Corporation (L) has filed a Form 144 notice for the planned sale of up to 200,000 common shares, valued at $21,574,000, through Watermill Institutional Trading, LLC on the NYSE. The shares were acquired via trust contributions in three transactions between December 2023 and December 2024. The filing indicates a low impact and neutral sentiment.

**5. Legal & General Group Plc Cuts Position in Bio-Techne Corp $TECH**
- Source: MarketBeat | 20251129T125150 | Neutral | Relevance: 73%
- Legal & General Group Plc reduced its stake in Bio-Techne Corp (NASDAQ:TECH) by 25.1% in the second quarter, selling 186,173 shares. Despite this, institutional ownership remains high at 98.95%, with other major investors increasing their positions. Bio-Techne reported mixed financial results, with EPS meeting expectations but revenue missing, and analysts maintain a "Moderate Buy" rating with a consensus price target of $70.92.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 10 ($0.09M) |
| Sells | 5 ($3.83M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- JPMORGAN CHASE & CO: 9.6% (+74.3%)
- Vanguard Group Inc: 9.3% (-1.6%)
- Blackrock Inc.: 6.8% (-3.5%)
- State Street Corpora: 3.8% (-2.4%)
- Geode Capital Manage: 2.3% (+2.6%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.69 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (3.2x), $1.0B free cash flow. Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $21.3B |
| Beta | 0.62 |
| 52W Range | $78.98 - $109.06 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.69 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | N/A |

### Technicals

MRS_10 deteriorating from 1.5% to -2.1% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.10% (CS: 25) | Weak |
| RSI_14 | 63.8 | Neutral |
| MACD Histogram | 0.21 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 1.045x | Above |
| vs SMA200 | 1.146x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $106.40
- **Stop Loss:** $103.36 (2.9% risk)
- **Target:** $109.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 328
- **Position Value:** $34,899.20
- **Portfolio %:** 34.90%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-09 (Est: $0.00)

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*